GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kobayashi Pharmaceutical Co Ltd (OTCPK:KBYPF) » Definitions » Shiller PE Ratio

KBYPF (Kobayashi Pharmaceutical Co) Shiller PE Ratio : 22.25 (As of Sep. 22, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Kobayashi Pharmaceutical Co Shiller PE Ratio?

As of today (2024-09-22), Kobayashi Pharmaceutical Co's current share price is $32.485. Kobayashi Pharmaceutical Co's E10 for the quarter that ended in Jun. 2024 was $1.46. Kobayashi Pharmaceutical Co's Shiller PE Ratio for today is 22.25.

The historical rank and industry rank for Kobayashi Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

KBYPF' s Shiller PE Ratio Range Over the Past 10 Years
Min: 20.97   Med: 45.14   Max: 67.8
Current: 24.14

During the past years, Kobayashi Pharmaceutical Co's highest Shiller PE Ratio was 67.80. The lowest was 20.97. And the median was 45.14.

KBYPF's Shiller PE Ratio is ranked worse than
61.52% of 1037 companies
in the Consumer Packaged Goods industry
Industry Median: 18.48 vs KBYPF: 24.14

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Kobayashi Pharmaceutical Co's adjusted earnings per share data for the three months ended in Jun. 2024 was $0.039. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $1.46 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kobayashi Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Kobayashi Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobayashi Pharmaceutical Co Shiller PE Ratio Chart

Kobayashi Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.06 67.31 44.59 41.33 28.72

Kobayashi Pharmaceutical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.55 28.47 28.72 21.02 22.19

Competitive Comparison of Kobayashi Pharmaceutical Co's Shiller PE Ratio

For the Household & Personal Products subindustry, Kobayashi Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kobayashi Pharmaceutical Co's Shiller PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kobayashi Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Kobayashi Pharmaceutical Co's Shiller PE Ratio falls into.



Kobayashi Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Kobayashi Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=32.485/1.46
=22.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobayashi Pharmaceutical Co's E10 for the quarter that ended in Jun. 2024 is calculated as:

For example, Kobayashi Pharmaceutical Co's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0.039/108.2000*108.2000
=0.039

Current CPI (Jun. 2024) = 108.2000.

Kobayashi Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201409 0.345 98.500 0.379
201412 0.537 97.900 0.593
201503 0.181 97.900 0.200
201506 0.286 98.400 0.314
201509 0.319 98.500 0.350
201512 0.647 98.100 0.714
201603 0.114 97.900 0.126
201606 0.616 98.100 0.679
201609 0.354 98.000 0.391
201612 0.672 98.400 0.739
201703 0.388 98.100 0.428
201706 0.410 98.500 0.450
201709 0.538 98.800 0.589
201712 0.462 99.400 0.503
201803 0.456 99.200 0.497
201806 0.438 99.200 0.478
201809 0.693 99.900 0.751
201812 0.480 99.700 0.521
201903 0.420 99.700 0.456
201906 0.533 99.800 0.578
201909 0.836 100.100 0.904
201912 0.457 100.500 0.492
202003 0.445 100.300 0.480
202006 0.532 99.900 0.576
202009 0.853 99.900 0.924
202012 0.487 99.300 0.531
202103 0.427 99.900 0.462
202106 0.494 99.500 0.537
202109 0.813 100.100 0.879
202112 0.544 100.100 0.588
202203 0.378 101.100 0.405
202206 0.408 101.800 0.434
202209 0.614 103.100 0.644
202212 0.534 104.100 0.555
202303 0.355 104.400 0.368
202306 0.395 105.200 0.406
202309 0.678 106.200 0.691
202312 0.448 106.800 0.454
202403 0.088 107.200 0.089
202406 0.039 108.200 0.039

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kobayashi Pharmaceutical Co  (OTCPK:KBYPF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Kobayashi Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Kobayashi Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kobayashi Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
KDX Kobayashi Doshomachi Building, 4-4-10 Doshomachi, Chuo-ku, Osaka, JPN, 541-0045
Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers, and skincare. Kobayashi mainly sells its products in drugstores, convenience stores, and general merchandise stores, or GMSes. It has a geographical presence in Japan and is expanding overseas business in the U.S., China, and Southeast Asia.

Kobayashi Pharmaceutical Co Headlines

No Headlines